OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00070359

Hengyi Petrochemical Co Ltd

Commodity ChemicalsVerified

Hengyi Petrochemical operates with a capital structure that is heavily leveraged, as evidenced by a debt-to-equity ratio of 2.75, which is significantly higher than the typical leverage for firms in the Commodity Chemicals industry. The company's liquidity position is medium, with a current ratio of 0.55, indicating that it has less than half the current assets to cover its current liabilities. Free cash flow is negative at -3.97 billion CNY, and capital expenditures are substantial at -5.5 billion CNY, suggesting ongoing investment in infrastructure or expansion. Profitability metrics for Hengyi Petrochemical are weak compared to industry norms. Return on equity (ROE) is 1.06%, and return on assets (ROA) is 0.24%, both of which are below the median for the Commodity Chemicals industry. Gross profit of 5.07 billion CNY and operating income of 443.97 million CNY indicate that the company is generating modest margins, which may be constrained by high input costs or competitive pricing pressures. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification beyond China. This concentration increases exposure to domestic economic conditions and regulatory changes. No specific geographic breakdown is provided in the available data, but the company's operations are primarily based in China. Hengyi Petrochemical's growth trajectory appears to be modest, with no specific revenue growth rates provided in the available data. However, the company's capital expenditures suggest a focus on maintaining or expanding production capacity. Analysts have assigned a mean price target of 16.00 CNY, with a mean recommendation of 1.33, indicating a generally positive outlook, though not strongly bullish. The company faces several risk factors, including high leverage and negative free cash flow, which could limit its ability to fund operations or invest in growth without external financing. The risk assessment indicates a low probability of dilution, but the presence of long-term debt at 67.08 billion CNY and a negative net cash position suggests potential refinancing risks. No specific dilution sources are identified in the available data. Recent events include the publication of the latest financial data, which shows a net income of 258.33 million CNY. No recent filings or transcripts are available in the provided data, so the company's strategic direction and operational performance must be inferred from its financial results and analyst estimates.

30-day price · 000703+2.65 (+21.7%)
Low$12.01High$18.35Close$14.84As of15 May, 00:00 UTC
Profile
CompanyHengyi Petrochemical Co Ltd
Ticker000703.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Hengyi Petrochemical Co Ltd is a Chinese chemical manufacturing company that produces and sells commodity chemicals, primarily generating revenue through the production and sale of petrochemical products.

Classification. Hengyi Petrochemical is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

Hengyi Petrochemical operates with a capital structure that is heavily leveraged, as evidenced by a debt-to-equity ratio of 2.75, which is significantly higher than the typical leverage for firms in the Commodity Chemicals industry. The company's liquidity position is medium, with a current ratio of 0.55, indicating that it has less than half the current assets to cover its current liabilities. Free cash flow is negative at -3.97 billion CNY, and capital expenditures are substantial at -5.5 billion CNY, suggesting ongoing investment in infrastructure or expansion. Profitability metrics for Hengyi Petrochemical are weak compared to industry norms. Return on equity (ROE) is 1.06%, and return on assets (ROA) is 0.24%, both of which are below the median for the Commodity Chemicals industry. Gross profit of 5.07 billion CNY and operating income of 443.97 million CNY indicate that the company is generating modest margins, which may be constrained by high input costs or competitive pricing pressures. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification beyond China. This concentration increases exposure to domestic economic conditions and regulatory changes. No specific geographic breakdown is provided in the available data, but the company's operations are primarily based in China. Hengyi Petrochemical's growth trajectory appears to be modest, with no specific revenue growth rates provided in the available data. However, the company's capital expenditures suggest a focus on maintaining or expanding production capacity. Analysts have assigned a mean price target of 16.00 CNY, with a mean recommendation of 1.33, indicating a generally positive outlook, though not strongly bullish. The company faces several risk factors, including high leverage and negative free cash flow, which could limit its ability to fund operations or invest in growth without external financing. The risk assessment indicates a low probability of dilution, but the presence of long-term debt at 67.08 billion CNY and a negative net cash position suggests potential refinancing risks. No specific dilution sources are identified in the available data. Recent events include the publication of the latest financial data, which shows a net income of 258.33 million CNY. No recent filings or transcripts are available in the provided data, so the company's strategic direction and operational performance must be inferred from its financial results and analyst estimates.
Key takeaways
  • Hengyi Petrochemical is a highly leveraged chemical manufacturer with a debt-to-equity ratio of 2.75.
  • The company's profitability is weak, with ROE of 1.06% and ROA of 0.24%.
  • Revenue is concentrated in a single business segment, with no geographic diversification beyond China.
  • Analysts have a generally positive outlook, with a mean price target of 16.00 CNY and a mean recommendation of 1.33.
  • The company faces liquidity and refinancing risks due to high debt and negative free cash flow.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$113.53B
Gross profit$5.07B
Operating income$444.0M
Net income$258.3M
R&D
SG&A
D&A
SBC
Operating cash flow$4.63B
CapEx-$5.50B
Free cash flow-$3.97B
Total assets$109.63B
Total liabilities$85.24B
Total equity$24.39B
Cash & equivalents
Long-term debt$67.08B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$113.53B$444.0M$258.3M-$3.97B
FY-1$125.46B$63.5M$233.9M-$3.98B
FY-2$136.15B$423.6M$435.5M-$3.89B
FY-3$152.05B-$1.11B-$1.08B-$3.49B
FY-4$128.98B$4.29B$3.41B-$2.12B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$109.63B$24.39B
FY-1$107.53B$24.74B
FY-2$108.05B$25.21B
FY-3$111.96B$25.45B
FY-4$105.52B$25.87B
PeriodOCFCapExFCFSBC
FY0$4.63B-$5.50B-$3.97B
FY-1$6.00B-$4.44B-$3.98B
FY-2$4.53B-$4.93B-$3.89B
FY-3$2.71B-$2.96B-$3.49B
FY-4$7.75B-$6.01B-$2.12B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$29.95B$2.92B$1.99B
FQ-1$29.64B$92.0M$27.2M
FQ-2$27.93B$28.0M$4.4M
FQ-3$28.79B$212.6M$175.2M
FQ-4$27.17B$113.9M$51.5M
FQ-5$30.65B-$189.4M$3.0M
FQ-6$30.05B-$344.7M-$199.4M
FQ-7$33.11B$56.0M$16.6M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$121.12B$27.12B$12.63B
FQ-1$109.63B$24.39B
FQ-2$111.51B$24.46B$10.67B
FQ-3$109.77B$24.63B
FQ-4$111.00B$24.64B$12.64B
FQ-5$107.53B$24.74B
FQ-6$109.93B$24.43B$12.14B
FQ-7$110.87B$25.29B
PeriodOCFCapExFCFSBC
FQ0-$2.57B-$1.44B
FQ-1$4.63B-$5.50B
FQ-2$340.2M-$4.05B
FQ-3-$181.5M-$2.82B
FQ-4-$3.84B-$1.20B
FQ-5$6.00B-$4.44B
FQ-6$484.6M-$2.79B
FQ-7$97.3M-$1.66B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$24.39B
Net cash-$67.08B
Current ratio0.6
Debt/Equity2.8
ROA0.2%
ROE1.1%
Cash conversion17.9%
CapEx/Revenue-4.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric000703Activity
Op margin0.4%0.4% medp25 -8.0% · p75 16.0%below median
Net margin0.2%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin4.5%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-4.9%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity275.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target16.00 CNY
Median price target16.00 CNY
High price target16.00 CNY
Low price target16.00 CNY
Mean recommendation1.33 (1=strong buy, 5=strong sell)
Strong-buy count2.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.77 CNY
Last actual EPS0.08 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-17 03:17 UTCJob: a3aa99ed